Zocil® is a preparation of cilostazole. The mechanism of action is to specifically inhibit cellular phosphodiesterase III (PDE III) and suppress cAMP degradation with a resultant increase in cAMP in platelets and blood vessels, leading to inhibition of pla

  • Relives the signs & symptoms of IC effectively
  • Significantly improves Maximal Walking Distance (MWD) & Pain-free Walking Distance (PFWD)
  • Offers better pharmacotheraphy in IC
  • Offers a new therapeutic option to prevent recurrent cerebral infraction
  • Offers positive effective on lipid profile
  • Offers safety to elderly
  • Builds confidence of treatment success
  • Offers patients? compliance

Zocil Prescribing Information

Located in: Other Products